STANKOVICH THOMAS

Average Profitability
4.59%
Insider Buys Quantity
6
Insider Buys Sum
$180,508.64
Insider Sells Quantity
33
Insider Sells Sum
$276,099.91

Insider Activity of STANKOVICH THOMAS

According to the SEC Form 4 filings, STANKOVICH THOMAS, being in a position of

  1. Chief Financial Officer at ReShape Lifesciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 133 shares for $30,
    over all time since 2020-08-19, has bought 73035 shares for $180,509, and sold 489627 shares for $276,100.

The largest purchase of all time was on 2021-08-30 and amounted to 15000 shares of ReShape Lifesciences Inc. for $51,435.

The largest sale of all time was on 2021-09-10 and amounted to 48366 shares of ReShape Lifesciences Inc. for $139,778.

Biography of STANKOVICH THOMAS

No biography is available at this moment.

2024-05-31SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
48
0.0002%
$0.25$12-36.81%
2024-02-29SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
43
0.0002%
$0.17$7-0.2%
2023-12-31SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
42
0.0003%
$0.25$11-31.72%
2023-11-30SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
39
0.0003%
$0.23$9-23.32%
2023-10-25SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
131
0.0027%
$0.27$35-26%
2023-10-11SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
39
0.0026%
$0.93$36-28.83%
2023-09-01SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
118
0.0034%
$0.89$105-77.6%
2023-08-24SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
39
0.0013%
$1.42$55-82.09%
2023-08-04SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
108
0.0036%
$1.43$154-84.79%
2023-07-06SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
106
0.0064%
$1.47$156-83.66%
2023-06-30PurchaseReShape Lifesciences Inc.
RSLS
Chief Financial Officer
17,702
1.0643%
$1.52$26,907-84.1%
2023-05-31SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
98
0.0057%
$2.41$236-89.68%
2023-04-30SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
96
<0.0001%
$2.36$227-64.13%
2023-03-31SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
109
<0.0001%
$2.60$283-85.04%
2023-02-28SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
103
<0.0001%
$4.25$438-76.97%
2023-02-02SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
157
<0.0001%
$13.29$2,087-78.25%
2023-01-24SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
158
<0.0001%
$7.49$1,183-81.24%
2022-12-01SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
7,357
0.0335%
$0.15$1,112-69.71%
2022-11-28SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
364,756
1.9555%
$0.17$61,826-68.05%
2022-11-04SaleReShape Lifesciences Inc.
RSLS
Chief Financial Officer
8,393
0.0385%
$0.27$2,287-82.14%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.